First drug to slow Alzheimer’s disease could soon be on the market

First drug to slow Alzheimer’s disease could soon be on the market A potentially “ground-breaking” drug which appears to slow Alzheimer’s disease could soon change the lives of thousands of dementia sufferers.

The treatment offers new hope to patients in the early stages of the most common form of dementia, which affects about 850,000 people living in the UK.

Biogen says its drug, aducanumab, would be the first treatment to “reduce the clinical decline” of patients in the early stages of Alzheimer’s disease if approved. The Independent

See also:

• First drug to slow Alzheimer's may be available soon BBC News